Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
PfizerPFE |
$13M |
 |
AstrazenecaAZN |
-$480,000 |
 |
Johnson & JohnsonJNJ |
-$631M |
 |
ModernaMRNA |
-$1.8B |
 |
AbbVieABBV |
-$378M |
Are Organogenesis Insiders Buying or Selling?
Organogenesis (ORGO) has had no reported insider transactions in the past 90 days. The most recent was Driscoll Michael Joseph, who bought 10,000 shares at $2.67 on March 9, 2026.
Insider trading patterns can signal confidence or concern from the people who know the company best. AltIndex tracks insider transactions as one of 25+ alternative data signals in the ORGO AI Score. For government officials trading this stock, see ORGO congressional trading.
Who’s Trading Organogenesis Stock?
| Insider | Activity | Trades | Last Trade |
|---|---|---|---|
| GLENN NUSSDORF | Sold $2.7M | 8 | Dec 16, 2025 |
| Gary Gillheeney | Sold $1.4M | 7 | Dec 16, 2024 |
| Lori Freedman | Bought $730,000 | 3 | Jun 6, 2025 |
| Driscoll Michael Joseph | Sold $130,000 | 2 | Mar 9, 2026 |
| Arthur Leibowitz | Bought $13,000 | 1 | Mar 9, 2026 |
Recent Organogenesis Insider Transactions
| Insider | Transaction Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Driscoll Michael Joseph | Mar 9, 2026 | Buy | 10,000 | $2.67 | $27,000 |
| Arthur Leibowitz | Mar 9, 2026 | Buy | 5,000 | $2.68 | $13,000 |
| GLENN NUSSDORF | Dec 16, 2025 | Sell | 200,000 | $5.14 | $1M |
| GLENN NUSSDORF | Nov 26, 2025 | Sell | 187,957 | $5.29 | $990,000 |
| GLENN NUSSDORF | Nov 25, 2025 | Sell | 12,043 | $5.3 | $64,000 |
| GLENN NUSSDORF | Nov 24, 2025 | Sell | 100,000 | $5.34 | $530,000 |
| GLENN NUSSDORF | Jun 10, 2025 | Sell | 18,620 | $3.56 | $66,000 |
| GLENN NUSSDORF | Jun 9, 2025 | Sell | 4,156 | $3.5 | $15,000 |
| Lori Freedman | Jun 6, 2025 | Buy | 9,022 | $2.99 | $27,000 |
| Lori Freedman | Jun 5, 2025 | Buy | 142,379 | $2.91 | $410,000 |
| Lori Freedman | Jun 4, 2025 | Buy | 100,863 | $2.82 | $280,000 |
| GLENN NUSSDORF | May 15, 2025 | Buy | 107,494 | $2.99 | $320,000 |
| GLENN NUSSDORF | May 14, 2025 | Buy | 251,001 | $3.09 | $780,000 |
| Driscoll Michael Joseph | Mar 4, 2025 | Sell | 25,000 | $5.1 | $130,000 |
| Gary Gillheeney | Dec 16, 2024 | Sell | 5,585 | $3.49 | $19,000 |
| Gary Gillheeney | Dec 13, 2024 | Sell | 55,615 | $3.36 | $190,000 |
| Gary Gillheeney | Dec 12, 2024 | Sell | 43,359 | $3.55 | $150,000 |
| Gary Gillheeney | Dec 11, 2024 | Sell | 157,448 | $3.64 | $570,000 |
| Gary Gillheeney | Dec 10, 2024 | Sell | 58,525 | $3.64 | $210,000 |
| Gary Gillheeney | Dec 9, 2024 | Sell | 41,052 | $3.52 | $140,000 |
| Gary Gillheeney | Dec 6, 2024 | Sell | 18,416 | $3.65 | $67,000 |
Frequently Asked Questions: Organogenesis Insider Trading
Organogenesis insiders have not reported any transactions in the past 90 days.
The most recent sale was by GLENN NUSSDORF who sold 200,000 shares on December 16, 2025. View all transactions in the table on this page.
Insider buying is generally a stronger signal than insider selling, since insiders may sell for personal reasons (diversification, taxes) but typically buy only when they believe the stock is undervalued. AltIndex uses insider transaction patterns alongside 25+ other signals in the AI Score.
NUSSDORF GLENN H has bought the most ORGO stock in the last 2 years, with a total value of $1.1M.
NUSSDORF GLENN H has sold the most ORGO stock in the last 2 years, with a total value of $2.7M.
The total value of insider transactions for Organogenesis in the last 2 years is negative, amounting to -$2.3M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
